Doudou Jing

1.7k total citations
31 papers, 1.4k citations indexed

About

Doudou Jing is a scholar working on Molecular Biology, Biomedical Engineering and Cancer Research. According to data from OpenAlex, Doudou Jing has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Biomedical Engineering and 8 papers in Cancer Research. Recurrent topics in Doudou Jing's work include Nanoplatforms for cancer theranostics (8 papers), Cancer-related molecular mechanisms research (4 papers) and Extracellular vesicles in disease (4 papers). Doudou Jing is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Cancer-related molecular mechanisms research (4 papers) and Extracellular vesicles in disease (4 papers). Doudou Jing collaborates with scholars based in China, Hong Kong and Maldives. Doudou Jing's co-authors include Dong Zheng, Xiangmei Liu, Shuilin Wu, Shengli Zhu, Zhenduo Cui, Kwk Yeung, Yanqin Liang, Zhaoyang Li, Xianjin Yang and Xianbao Wang and has published in prestigious journals such as ACS Nano, Advanced Functional Materials and ACS Applied Materials & Interfaces.

In The Last Decade

Doudou Jing

29 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doudou Jing China 16 637 431 388 224 174 31 1.4k
Qi‐Wen Chen China 21 827 1.3× 390 0.9× 389 1.0× 154 0.7× 91 0.5× 66 1.6k
Luyao Sun China 24 491 0.8× 379 0.9× 350 0.9× 96 0.4× 112 0.6× 59 1.4k
Xiuguo Han China 24 1.1k 1.8× 780 1.8× 902 2.3× 85 0.4× 183 1.1× 34 2.6k
Dong Zheng China 13 802 1.3× 549 1.3× 154 0.4× 255 1.1× 28 0.2× 22 1.3k
Qiuyue Ding China 18 301 0.5× 210 0.5× 238 0.6× 91 0.4× 84 0.5× 48 935
Changyu Cao China 17 1.3k 2.0× 1.1k 2.5× 343 0.9× 161 0.7× 42 0.2× 25 1.8k
Kunyan Lu China 20 355 0.6× 198 0.5× 312 0.8× 164 0.7× 41 0.2× 30 1.0k
Zhuobin Xu China 21 686 1.1× 835 1.9× 413 1.1× 71 0.3× 35 0.2× 40 1.5k
Chuanxu Yang Denmark 23 354 0.6× 270 0.6× 676 1.7× 144 0.6× 112 0.6× 43 1.5k

Countries citing papers authored by Doudou Jing

Since Specialization
Citations

This map shows the geographic impact of Doudou Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doudou Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doudou Jing more than expected).

Fields of papers citing papers by Doudou Jing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doudou Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doudou Jing. The network helps show where Doudou Jing may publish in the future.

Co-authorship network of co-authors of Doudou Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Doudou Jing. A scholar is included among the top collaborators of Doudou Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doudou Jing. Doudou Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaonan, Binghong Chen, Haifeng Liu, et al.. (2025). Mechanism of lidocaine-induced ROS generation triggering DNA double-strand breaks and promoting intervertebral disc cell senescence via the MYC-DUSP1-P53 axis. Free Radical Biology and Medicine. 240. 457–471. 1 indexed citations
2.
Wang, Xiaonan, Xiaotian Ma, Jie Li, et al.. (2025). Precision prediction of intervertebral disc degeneration in ankylosing spondylitis using a nomogram model reveals the pivotal role of Th2-type immune dysregulation. Frontiers in Immunology. 16. 1556738–1556738. 1 indexed citations
3.
Jing, Doudou, Xin Huang, Xuanzuo Chen, et al.. (2025). Transketolase promotes osteosarcoma progression through the YY1PAK4 axis. FEBS Journal. 292(7). 1798–1812.
5.
Ke, Jia, Li Cao, Yihan Yu, et al.. (2024). Signaling pathways and targeted therapies in Ewing sarcoma. Pharmacology & Therapeutics. 266. 108765–108765. 2 indexed citations
6.
Jing, Doudou, et al.. (2023). Management of pain in patients with bone metastases. Frontiers in Oncology. 13. 1156618–1156618. 22 indexed citations
7.
Jing, Doudou, Xuanzuo Chen, Zhenghao Zhang, et al.. (2023). 2-Hydroxy-3-methylanthraquinone inhibits homologous recombination repair in osteosarcoma through the MYC-CHK1-RAD51 axis. Molecular Medicine. 29(1). 15–15. 3 indexed citations
9.
Huang, Xin, Wei Wu, Doudou Jing, et al.. (2022). Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy. Journal of Controlled Release. 343. 107–117. 131 indexed citations
10.
Wu, Wei, Zhenghao Zhang, Doudou Jing, et al.. (2022). SGLT2 inhibitor activates the STING/IRF3/IFN-β pathway and induces immune infiltration in osteosarcoma. Cell Death and Disease. 13(6). 523–523. 54 indexed citations
11.
Jing, Doudou, Wei Wu, Xuanzuo Chen, et al.. (2022). Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of JAK2 Via the JAK2-STAT3-PDL1. Pharmacological Research. 182. 106287–106287. 44 indexed citations
12.
Wu, Wei, Haoyu Guo, Doudou Jing, et al.. (2022). Targeted Delivery of PD‐L1‐Derived Phosphorylation‐Mimicking Peptides by Engineered Biomimetic Nanovesicles to Enhance Osteosarcoma Treatment. Advanced Healthcare Materials. 11(23). 22 indexed citations
14.
Pu, Feifei, Wei Wu, Doudou Jing, et al.. (2022). Three-dimensional-printed titanium prostheses with bone trabeculae enable mechanical-biological reconstruction after resection of bone tumours.. PubMed. 3(2). 134–141. 7 indexed citations
15.
Huang, Xin, Haoyu Guo, Lutong Wang, et al.. (2021). Exosomes as Efficient Nanocarriers in Osteosarcoma: Biological Functions and Potential Clinical Applications. Frontiers in Cell and Developmental Biology. 9. 737314–737314. 20 indexed citations
16.
Jing, Doudou, Zibo Meng, Binwu Hu, et al.. (2020). FGD1 promotes tumor progression and regulates tumor immune response in osteosarcoma via inhibiting PTEN activity. Theranostics. 10(6). 2859–2871. 42 indexed citations
17.
Wang, Xiuhua, Kun Su, Lei Tan, et al.. (2019). Rapid and Highly Effective Noninvasive Disinfection by Hybrid Ag/CS@MnO2 Nanosheets Using Near-Infrared Light. ACS Applied Materials & Interfaces. 11(16). 15014–15027. 99 indexed citations
18.
Deng, Xiangyu, Doudou Jing, Hang Liang, Dong Zheng, & Zengwu Shao. (2019). H₂O₂ Damages the Stemness of Rat Bone Marrow-Derived Mesenchymal Stem Cells: Developing a “Stemness Loss” Model. Medical Science Monitor. 25. 5613–5620. 6 indexed citations
19.
Huang, Donghua, Yizhong Peng, Kaige Ma, et al.. (2018). MiR-20a, a novel promising biomarker to predict prognosis in human cancer: a meta-analysis. BMC Cancer. 18(1). 1189–1189. 15 indexed citations
20.
Deng, Xiangyu, Wei Wu, Hang Liang, et al.. (2017). Icariin Prevents IL‐1β‐Induced Apoptosis in Human Nucleus Pulposus via the PI3K/AKT Pathway. Evidence-based Complementary and Alternative Medicine. 2017(1). 2198323–2198323. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026